剪切波弹性成像-虚拟触诊成像量化技术在乳腺肿块评估中的诊断准确性:对超声特异度的影响及其最终临床获益
该前瞻性研究纳入357例女性396个乳腺肿块,评估剪切波弹性成像-虚拟触诊成像量化(SWE-VTIQ)作为超声补充的诊断效能与临床获益。结果显示SWE-VTIQ可提高超声特异度,仅用于BI-RADS 4A肿块时假阳性率降低25%,维持高敏感度98.9%(95%CI 97.1-100%)和阴性预测值95.5%;同时用于4A和4B时假阳性率降低54.4%,但会漏诊13例恶性(占全部恶性4.7%)。
要点
- SWE-VTIQ可提高超声特异度,但仅用于BI-RADS 4A肿块时获益明确。
- 仅用于BI-RADS 4A时假阳性率降低25%,敏感度98.9%(95%CI 97.1-100%)。
- 同时用于4A和4B时假阳性率降低54.4%,但漏诊13例恶性(占全部恶性4.7%)。
核心结论
- SWE-VTIQ用于BI-RADS 4A病变时可提高超声特异度,显著减少不必要的干预并保留恶性病变诊断;若同时用于BI-RADS 4B病变则假阴性病例增多,应谨慎评估。
研究设计与样本
- 前瞻性研究,2016年10月至2017年6月纳入357例女性396个乳腺肿块,行B型超声和SWE-VTIQ检查,以组织病理学为良性或恶性判定的参考标准。
关键影像表现/征象
- 396个肿块中122个(30.8%)为良性,274个(69.2%)为恶性。
- 所有SWE参数在恶性肿块中均显著更高(均p<0.01)。
- Vmax和Vratio(max)的诊断效能显著优于Vratio(mean)(分别为p=0.01和p=0.03)。
诊断标准与关键数值
- SWE-VTIQ在除BI-RADS 3病变外的所有诊断策略中均提高超声特异度。
- 仅用于BI-RADS 4A肿块时假阳性率降低25%,敏感度98.9%(95%CI 97.1-100%),阴性预测值95.5%。
- 用于BI-RADS 4A和4B肿块时假阳性率降低54.4%,但漏诊13例恶性(占全部恶性病例的4.7%)。
临床应用与阅片要点
- SWE-VTIQ可作为超声的补充用于BI-RADS 4A病变,以减少不必要的干预。
- 将SWE-VTIQ同时用于BI-RADS 4B病变时需谨慎评估,因假阴性病例增多。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To evaluate the diagnostic performance and the clinical benefit of Shear-Wave Elastography - Virtual Touch™ Imaging Quantification (SWE-VTIQ) as a complement to ultrasonography (US).
METHODS: From October 2016 through Jun 2017, B-mode US and SWE-VTIQ were prospectively performed in 396 breast masses in 357 women who consented to undergo this study. Quantitative elastography values were recorded: Vmax (maximum elasticity), Vmean (median elasticity), Vratio(max) (ratio of Vmax and surrounding parenchyma) and Vratio(mean) (ratio of Vmean and surrounding parenchyma). The histopathology of the lesions was considered the reference standard for benign or malignant definition. The performance of the four elastographic parameters was evaluated trough sensitivity, specificity and AUC. The parameter with the best performance was tested in six different diagnostic approaches defined based on clinical practice.
RESULTS: Of the 396 masses, 122 (30.8%) were benign and 274 (69.2%) were malignant. All SWE parameters were significantly higher in malignant masses (all p < 0.01). Vmax and Vratio(max) performed significantly better then Vratio(mean) (p = 0.01 and p = 0.03, respectively). SWE-VTIQ improved US specificity in all diagnostic approaches, except when applied to BI-RADS 3 lesions. SWE-VTIQ reduced the false positive rate in 25% if applied only to BI-RADS 4A masses, maintaining a high sensitivity (98.9%, 95% confidence interval 97.1-100%) and a negative predictive value of 95.5%. When applied to BI-RADS 4A and 4B masses, SWE-VTIQ reduced the false positive rate in 54.4%. However, 13 malignant cases would be missed in this approach (4.7% of all malignant cases).
CONCLUSIONS: SWE-VTIQ increases US specificity when applied to BI-RADS 4 A lesions, significantly reducing unnecessary interventions and preserving the diagnosis of malignant lesions. When applied also to BI-RADS® 4B lesions, SWE-VTIQ increases the number of false negative cases, which should be evaluated with caution.
引用
- Dória MT, Jales RM, Conz L, et al. Diagnostic accuracy of shear wave elastography - Virtual touch™ imaging quantification in the evaluation of breast masses: Impact on ultrasonography's specificity and its ultimate clinical benefit. Eur J Radiol. 2019. PMID: 30927963. doi:10.1016/j.ejrad.2019.02.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。